Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, April 11, 2022
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
[ Mon, Apr 11th 2022
] - WOPRAI
Robert Burns Maintained (AADI) at Strong Buy with Decreased Target to $720 on, Apr 11th, 2022
Robert Burns of HC Wainwright & Co., Maintained "Aadi Bioscience, Inc." (AADI) at Strong Buy with Decreased Target from $735 to $720 on, Apr 11th, 2022.
Robert has made no other calls on AADI in the last 4 months.
There is 1 other peer that has a rating on AADI. Out of the 1 peers that are also analyzing AADI, 0 agree with Robert's Rating of Hold.
This is the rating of the analyst that currently disagrees with Robert
- Roger Song of "Jefferies" Initiated at Strong Buy and Held Target at $675 on, Tuesday, January 11th, 2022
